医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

WIL Research Partners with Three S Japan to Expand Full Portfolio of Global Safety Assessment Services to the Japanese Market

2013年05月16日 AM08:25
このエントリーをはてなブックマークに追加


 

ASHLAND, Ohio & TOKYO

WIL Research, a leading global CRO in the pharmaceutical, chemical and agrochemical industries, is partnering with Three S Japan, a company that provides support services in these industries, to represent its full portfolio of global safety assessment services in Japan.

WIL Research offers a blend of technical and regulatory expertise in discovery support, product safety toxicological research, metabolism, bioanalytical chemistry, analytical chemistry and formulation services. They chose the Japan-based company to represent these services on the basis of its extensive network of clients, leadership experience with both pharmaceutical and chemical industry safety assessment, and its commitment to providing tailored, local client service.

“Three S Japan has a strong reputation serving the country’s pharmaceutical industry with high quality regulatory services underpinned by exceptional client focus,” said David Spaight, Chairman and CEO of WIL Research. “Through this partnership, clients will benefit from direct access to staff that can harness the full portfolio of WIL Research’s global services.”

CEO and President of Three S Japan, Koichi Hagita said, “WIL Research’s excellent reputation and our long-term client relationships and regulatory experience in the Japanese market will boost both our companies’ potential for growth.”

Three S Japan has operational centers in Tokyo and Osaka for pharmaceutical regulatory registration services. The company provides toxicological support from pre-clinical to clinical development, and is experienced in the preparation, translation, and quality control checks of submission documents for New Drug Applications and Investigational New Drug applications. Three S Japan also offers personalized consulting tailored to clients’ needs.

WIL Research was recently one of the winners of the CRO Leadership Award for Quality, awarded annually to leaders in quality, productivity, regulatory, accessibility, and reliability.

Please visit www.wilresearch.com for our full range of services and capabilities.

About Three S Japan

Three S Japan Co., Ltd. supports the non-clinical and clinical trial development of pharmaceuticals throughout drug development. It also offers support services for agrochemicals, chemicals, veterinary drugs, medical equipment and cosmetics. For more information visit www.3sjapan.com.

About WIL Research

Located in the United States, Europe and Japan, WIL Research Company, Inc. is a privately held global Contract Research Organization (CRO) that provides product safety toxicological research, bioanalytical, and formulation services to the pharmaceutical, biotechnology, chemical, agrochemical, and food products industries, as well as manufacturing support for clinical trials. For more information visit www.wilresearch.com.

CONTACT

WIL Research
Katie Geitgey, 1-419-289-8700
katie.geitgey@wilresearch.com

Related Posts Plugin for WordPress, Blogger...
 

同じカテゴリーの記事 

  • Clover Biopharmaceuticals Completes RMB 62.8 Million Series A Financing
  • 三叶草生物制药完成6,280万元人民币A轮融资
  • Corindus Announces First Commercial Installation of CorPath® GRX System Outside of U.S.
  • Walmart, JD.com, IBM and Tsinghua University Launch a Blockchain Food Safety Alliance in China
  • ADCセラピューティクスが当社の新規抗体薬物複合体ADCT-402の第I相中間データを発表